- Home
- PMCB vs CELZ Comparison
PMCB vs CELZ Comparison
Compare PMCB & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- CELZ
- Stock Information
- Founded
- PMCB 1996
- CELZ 1998
- Country
- PMCB United States
- CELZ United States
- Employees
- PMCB N/A
- CELZ N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- PMCB Health Care
- CELZ Health Care
- Exchange
- PMCB Nasdaq
- CELZ Nasdaq
- Market Cap
- PMCB 6.7M
- CELZ 7.4M
- IPO Year
- PMCB N/A
- CELZ N/A
- Fundamental
- Price
- PMCB $1.04
- CELZ $3.39
- Analyst Decision
- PMCB
- CELZ
- Analyst Count
- PMCB 0
- CELZ 0
- Target Price
- PMCB N/A
- CELZ N/A
- AVG Volume (30 Days)
- PMCB 121.2K
- CELZ 32.0K
- Earning Date
- PMCB 09-15-2025
- CELZ 11-07-2025
- Dividend Yield
- PMCB N/A
- CELZ N/A
- EPS Growth
- PMCB N/A
- CELZ N/A
- EPS
- PMCB 0.01
- CELZ N/A
- Revenue
- PMCB N/A
- CELZ $6,000.00
- Revenue This Year
- PMCB N/A
- CELZ N/A
- Revenue Next Year
- PMCB N/A
- CELZ N/A
- P/E Ratio
- PMCB $163.65
- CELZ N/A
- Revenue Growth
- PMCB N/A
- CELZ N/A
- 52 Week Low
- PMCB $0.80
- CELZ $1.69
- 52 Week High
- PMCB $2.42
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- PMCB 52.01
- CELZ 51.48
- Support Level
- PMCB $0.94
- CELZ $3.11
- Resistance Level
- PMCB $1.06
- CELZ $3.37
- Average True Range (ATR)
- PMCB 0.08
- CELZ 0.17
- MACD
- PMCB 0.00
- CELZ -0.02
- Stochastic Oscillator
- PMCB 38.16
- CELZ 41.84
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.